Inventor profile of:

Catherine ROUGEOT

City:

Chevreuse

Country:

France

Published Applications:

22

Last publication date:

2016-11-24

Top Assignees for applications by Catherine ROUGEOT

The entities that hold a legal rights for patent applications filed by inventor ROUGEOT Catherine:

Recent patent applications by ROUGEOT Catherine

Catherine ROUGEOT from Chevreuse, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-11-24
US20160341744A1
Physics

Pharmaceutical compositions containing peptides derived from human BPLP protein

#2 | 2015-11-19
US20150329608A1
Chemistry; metallurgy

OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT

#3 | 2015-03-05
US20150065683A1
Chemistry; metallurgy

Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases

#4 | 2014-11-27
US20140349946A1
Chemistry; metallurgy

Methods for treating pain by administering peptides derived from human basic proline-rich lacrimal protein

#5 | 2014-07-10
US20140193843A1
Physics

USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER

#6 | 2012-02-09
US20120034604A1
Physics

USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER

#7 | 2011-10-06
US20110244491A1
Physics

Method for detecting human BPLP protein or a maturation product thereof

#8 | 2011-07-21
US20110178021A1
Chemistry; metallurgy

OPIORPHIN FOR USE AS A PSYCHOSTIMULANT AGENT

#9 | 2011-05-26
US20110124571A1
Chemistry; metallurgy

Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases

#10 | 2010-02-18
US20100041072A1
Human necessities

PROCESS FOR IDENTIFYING A LIGAND THAT BINDS TO THE NEP BINDING SITE FOR THE SMR1 PENTAPEPTIDE

#11 | 2009-12-03
US20090298109A1
Chemistry; metallurgy

METHOD FOR IDENTIFYING BPLP AND OPIORPHIN AGONISTS OR ANTAGONISTS

#12 | 2009-10-08
US20090253639A1
Chemistry; metallurgy

Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases

#13 | 2008-09-30
US10620462
-

Therapeutic use of the SMR1 protein and active derivatives thereof

#14 | 2008-09-09
US10451073
-

Treatment of mood disorders by administration of SMR1

#15 | 2008-08-28
US20080206230A1
Physics

Peptides derived from human BPLP protein

#16 | 2007-03-08
US20070054861A1
Human necessities

Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide

#17 | 2006-12-28
US20060292598A1
Chemistry; metallurgy

Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

#18 | 2006-12-28
US20060292596A1
Chemistry; metallurgy

Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

#19 | 2006-12-26
US10451064
-

Therapeutic uses of SMR1 peptides

#20 | 2006-11-09
US20060252921A1
Chemistry; metallurgy

Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

#21 | 2005-06-16
US20050130166A1
Chemistry; metallurgy

Cloning, sequencing and expression of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

#22 | 2005-04-28
US20050090656A1
Chemistry; metallurgy

Cloning, sequencing and expresssion of a gene encoding an eukaryotic amino acid racemase, and diagnostic, therapeutic, and vaccination applications of parasite and viral mitogens

InventorID:

832471 ⎘